Get the Stockscreener App
183.49
1.88%
3.38
After Hours:
183.49
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Quest Diagnostics Inc stock is traded at $183.49, with a volume of 556.19K.
It is up +1.88% in the last 24 hours and up +5.90% over the past month.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$180.11
Open:
$180.2
24h Volume:
556.19K
Relative Volume:
0.58
Market Cap:
$20.52B
Revenue:
$9.54B
Net Income/Loss:
$841.00M
P/E Ratio:
24.66
EPS:
7.44
Net Cash Flow:
$1.02B
1W Performance:
+1.02%
1M Performance:
+5.90%
6M Performance:
+6.67%
1Y Performance:
+18.97%
1-Day Range:
$180.20
$183.78
1-Week Range:
$177.04
$183.78
52-Week Range:
$146.17
$185.62
Quest Diagnostics Inc Stock (DGX) Company Profile
Name
Quest Diagnostics Inc
Sector
Industry
Phone
(973) 520-2700
Address
500 PLAZA DRIVE, SECAUCUS
Compare DGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
183.49 | 20.14B | 9.54B | 841.00M | 1.02B | 7.44 |
|
TMO
Thermo Fisher Scientific Inc
|
492.60 | 184.84B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.21 | 142.52B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
642.99 | 51.24B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
128.75 | 36.42B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.68 | 31.29B | 15.70B | 1.24B | 2.01B | 6.91 |
Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-17-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-23-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Aug-28-24 | Resumed | Evercore ISI | In-line |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Feb-07-24 | Upgrade | Jefferies | Hold → Buy |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-29-23 | Initiated | Piper Sandler | Neutral |
| May-02-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-03-23 | Upgrade | Citigroup | Sell → Neutral |
| Jan-23-23 | Initiated | Evercore ISI | In-line |
| Nov-17-22 | Downgrade | Citigroup | Neutral → Sell |
| Aug-22-22 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Feb-23-22 | Downgrade | UBS | Buy → Neutral |
| Feb-02-22 | Downgrade | Jefferies | Buy → Hold |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| May-04-21 | Upgrade | UBS | Neutral → Buy |
| Mar-12-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-21-20 | Upgrade | Argus | Hold → Buy |
| Jul-29-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jun-09-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-02-20 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-28-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Mar-27-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-19-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jul-15-19 | Downgrade | Goldman | Neutral → Sell |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-19 | Resumed | Credit Suisse | Neutral |
| Jan-31-19 | Downgrade | Argus | Buy → Hold |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-30-18 | Downgrade | Goldman | Buy → Neutral |
View All
Quest Diagnostics Inc Stock (DGX) Latest News
Quest Diagnostics says it's tracking a concerning drug trend in the workplace - Scripps News
Sentiment analysis tools applied to Quest Diagnostics IncorporatedJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Should you wait for a breakout in Quest Diagnostics IncorporatedPortfolio Update Summary & Capital Efficiency Focused Strategies - Newser
What are the future prospects of Quest Diagnostics IncorporatedBreakout Watch & Consistent Return Strategy Ideas - خودرو بانک
Is There Enough Volume to Lift Quest Diagnostics IncorporatedJuly 2025 Closing Moves & AI Enhanced Execution Alerts - beatles.ru
Is Quest Diagnostics Incorporated still worth holding after the dipJuly 2025 Levels & Weekly Momentum Stock Picks - Newser
Stock Analysis | Quest Diagnostics OutlookTechnical Weakness and Mixed Analyst Signals - AInvest
Pattern recognition hints at Quest Diagnostics Incorporated upsidePortfolio Growth Summary & Real-Time Buy Signal Alerts - Newser
Quest Diagnostics and the Future of Precision Medicine: Strategic Positioning in the Growing Pharmacogenomics Market - AInvest
Published on: 2025-09-05 02:16:44 - Newser
Order flow analysis tools used on Quest Diagnostics IncorporatedInflation Watch & Low Volatility Stock Recommendations - Newser
How to use a screener to detect Quest Diagnostics Incorporated breakoutsRecession Risk & Accurate Buy Signal Notifications - Newser
Multi asset correlation models including Quest Diagnostics IncorporatedWeekly Market Report & Daily Technical Forecast Reports - Newser
Should I average down on Quest Diagnostics Incorporated stockJuly 2025 Spike Watch & Capital Efficient Trade Techniques - خودرو بانک
Revolutionary 17-Gene Test: Quest Diagnostics Launches PGx Service to Transform Drug Prescriptions - Stock Titan
Analyzing net buyer seller activity in Quest Diagnostics IncorporatedWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Applying big data sentiment scoring on Quest Diagnostics IncorporatedWeekly Profit Analysis & AI Based Trade Execution Alerts - Newser
Is Quest Diagnostics Incorporated stock bottoming outPortfolio Performance Report & Weekly Breakout Stock Alerts - Newser
What to do if you’re stuck in Quest Diagnostics IncorporatedVolume Spike & Daily Growth Stock Tips - Newser
Can Quest Diagnostics Incorporated reach resistance levels soonMarket Movement Recap & Daily Entry Point Trade Alerts - خودرو بانک
Is Quest Diagnostics Incorporated forming a double bottomLayoff News & Real-Time Stock Entry Alerts - خودرو بانک
Measuring Quest Diagnostics Incorporated’s beta against major indices2025 Momentum Check & AI Enhanced Execution Alerts - Newser
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term - Yahoo Finance
Published on: 2025-09-03 04:57:25 - Newser
Developing predictive dashboards with Quest Diagnostics Incorporated dataJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Quest Diagnostics Incorporated’s volatility index tracking explainedEntry Point & Daily Oversold Bounce Ideas - Newser
How to interpret RSI for Quest Diagnostics Incorporated stockJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Statistical indicators supporting Quest Diagnostics Incorporated’s strengthDividend Hike & Accurate Entry/Exit Alerts - Newser
Historical volatility pattern of Quest Diagnostics Incorporated visualizedTake Profit & Verified Momentum Watchlists - Newser
Can Quest Diagnostics Incorporated sustain its profitabilityJuly 2025 News Drivers & Weekly High Conviction Ideas - خودرو بانک
Using AI based signals to follow Quest Diagnostics IncorporatedWeekly Trade Report & Community Verified Trade Alerts - Newser
Published on: 2025-09-03 03:12:35 - khodrobank.com
Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途牛牛
Custom strategy builders for tracking Quest Diagnostics IncorporatedGold Moves & Capital Efficient Trading Techniques - Newser
Can Quest Diagnostics Incorporated expand into new marketsQuarterly Profit Report & Risk Managed Investment Signals - خودرو بانک
What are Quest Diagnostics Incorporated’s earnings expectations2025 Top Gainers & Precise Entry and Exit Recommendations - خودرو بانک
Is Quest Diagnostics Incorporated part of any major indexJuly 2025 Final Week & Consistent Growth Equity Picks - خودرو بانک
Quest Diagnostics Incorporated stock momentum explainedMarket Activity Report & Fast Moving Stock Watchlists - Newser
707% Higher Fentanyl Rates: Quest Diagnostics Reveals Alarming Shift in Workplace Drug Testing Patterns - Stock Titan
How Investors May Respond To Quest Diagnostics (DGX) Expanding Michigan Lab Services Through Corewell Joint Venture - Yahoo Finance
Automated trading signals detected on Quest Diagnostics IncorporatedTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
Quest Diagnostics: Strategic Expansion and Market Dominance in the Evolving Lab Testing Industry - AInvest
Is Quest Diagnostics Incorporated a strong candidate for buy and hold2025 Year in Review & Smart Money Movement Alerts - خودرو بانک
What’s the recovery path for long term holders of Quest Diagnostics IncorporatedGold Moves & High Yield Equity Trading Tips - Newser
Quant Strategy Flags Quest Diagnostics Incorporated for EntryMarket Growth Review & Free Real-Time Market Sentiment Alerts - beatles.ru
What MACD and RSI say about Quest Diagnostics IncorporatedShare Buyback & Growth Focused Stock Pick Reports - Newser
Is Quest Diagnostics Incorporated stock reversal real or fakeForecast Cut & Growth-Oriented Investment Plans - Newser
Can you recover from losses in Quest Diagnostics IncorporatedPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser
Multi factor analysis applied to Quest Diagnostics IncorporatedJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - Newser
Quest Diagnostics Inc Stock (DGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):